Komori
Pharmarise Holdings (2796) · PolicyRestated

High-Quality Pharmaceutical Care Through Sharing Pharmaceutical Information

First written in FY2018. 3 of 5 entries say "Restated". Latest entry: FY2023.

5entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2018 – FY2021ReframedFY20222018: 120182019: 020192020: 120202021: 120212022: 120222023: 12023
Same theme, other companies
Digital–Expert Collaborative Information ProvisionA theme 4 companies write about · 0 as a headwind · 4 as a tailwind

1 other company's latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2023RestatedAnnual report

    「By collecting the latest medical and pharmaceutical information, the Group provides its pharmacists with the medical information required for dispensing, helping them fulfil their role as medication specialists. It also provides patients and local residents with pharmaceutical information that helps maintain and improve their health, and focuses on raising awareness of such information.」

    The company continues initiatives to share pharmaceutical information by collecting medical and pharmaceutical information, providing it to pharmacists, and raising awareness among patients and local residents.
  2. FY2022ReframedAnnual report

    「By collecting the latest medical and pharmaceutical information, the Group provides its pharmacists with the medical information required for dispensing, helping them fulfil their role as medication specialists. It also provides patients and local residents with pharmaceutical information that helps maintain and improve their health, and focuses on raising awareness of such information.」

    While the former standard wording of “sharing pharmaceutical information” is no longer evident, research and development activities have been reorganised around collecting medical and pharmaceutical information, providing it to pharmacists, and raising awareness among local residents.
  3. FY2021RestatedAnnual report

    「<r0>Basic Policies</r0> ① Contribution to community healthcare ② High-quality healthcare services for patients ③ Sharing of pharmaceutical information」

    The company continues to maintain the sharing of pharmaceutical information as one of its basic policies.
  4. FY2020RestatedAnnual report

    「<r0>Basic Policies</r0> ① Contribution to community healthcare ② High-quality healthcare services for patients ③ Sharing of pharmaceutical information」

    The company continues to maintain the sharing of pharmaceutical information as one of its basic policies.
  5. FY2018First statedAnnual report

    「<r0>Basic Policies</r0> ① Contribution to community healthcare ② High-quality healthcare services for patients ③ Sharing of pharmaceutical information」

    The company identified the sharing of pharmaceutical information as a basic policy alongside contributing to community healthcare and providing high-quality healthcare services.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Pharmarise Holdings's next results are scheduled for 2026-09-17. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
High-Quality Pharmaceutical Care Through Sharing Pharmaceutical Information | Pharmarise Holdings Corporation (2796) | Komori